Articles Archives - Page 20 of 711

FridayMar 14, 2025 9:00 am

Adageis to Launch Series A Funding Round, Seeking $10M in Growth Capital

Adageis is opening a Series A funding round, capital raise, aiming to raise $10 million for growth and expansion. The company previously closed a $2 million seed round in Q4 2024 to enhance operations and market reach. Adageis expects to exceed growth targets for Q1 2025, with strong market adoption of its AI-powered platform designed to streamline healthcare operations, optimize revenue, and improve patient care outcomes. The company has cut onboarding time from four weeks to one week, accelerating customer acquisition and revenue growth. Adageis, a healthcare technology company reshaping patient care through flexible AI-centric software solutions for healthcare organizations,…

ThursdayMar 13, 2025 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Is ‘One to Watch’

Soligenix has multiple late-stage assets with orphan and fast-track designations, providing a clear regulatory pathway toward potential approvals. The company’s pipeline has a total addressable market exceeding $2 billion, spanning rare diseases, inflammation, and biothreat applications. Soligenix has benefited from significant non-dilutive government funding, which reduces operational expenses and financial risk while supporting its public health initiatives. The company is well-positioned for multiple development and regulatory catalysts, and commercial milestones, with lead candidates in cutaneous T-cell lymphoma, psoriasis, oral mucositis, and Behçet’s disease. Soligenix is led by an experienced management team with a strong track record of success. Soligenix (NASDAQ:…

ThursdayMar 13, 2025 9:00 am

State of the Venture Debt Market and Outlook for 2025

As of March 2025, the venture debt market continues to experience rapid growth, fueled by evolving financing needs, technological advancements, and a dynamic economic landscape. According to Statista, the U.S. venture debt market is projected to reach $27.83 billion in 2025, with traditional venture debt accounting for approximately $23.94 billion of that total (Statista). This growth reflects an increasing demand for non-dilutive financing among startups and growth-stage companies seeking capital without giving up equity. Startups are increasingly turning to venture debt as an attractive alternative to equity financing, particularly in capital-intensive sectors such as biotechnology, artificial intelligence, and climate technology.…

WednesdayMar 12, 2025 9:00 am

Clene Inc. (NASDAQ: CLNN) to Present CNM-Au8(R) Updates at 37th Annual Roth Conference

The 37th Annual Roth Conference, to be held March 16-18 in Dana Point, California, will showcase the broadest group of companies in the event’s history, with senior executives from approximately 500 companies across various industries, including business services, consumer, healthcare, insurance, sustainability and technology, media and entertainment. Clene’s management will participate in a virtual fireside chat at 9:20 a.m. PST on March 18, as well as one-on-one investor meetings during the event. During the fireside chat and in investor meetings, the company will detail recent achievements and next steps for lead drug candidate CNM-Au8 for ALS and MS. Clene Inc.…

TuesdayMar 11, 2025 11:35 am

Exciting Networking and Growth Opportunities at the 37th Annual ROTH Conference

The highly anticipated 37th Annual ROTH Conference, hosted by Roth Capital Partners, will bring together an influential gathering of investors, entrepreneurs, executives, and professionals from across a diverse range of industries. Taking place March 16-18, 2025, at the Laguna Cliffs Marriott in Dana Point, California, this premier event promises to provide participants with unmatched opportunities for networking, collaboration, and business growth. This year’s conference will feature executives from over 500 public and private companies across a broad spectrum of sectors, including technology, healthcare, industrial growth, sustainability, media and entertainment, and more. The ROTH Conference is designed as a dynamic platform…

FridayMar 07, 2025 11:30 am

Brera Holdings PLC (NASDAQ: BREA) Marks New Chapter with Signed LOI to Invest in Mozambican Moçambola 2024 Champion Black Bulls

Brera Holdings, an Ireland-based, international holding company, has signed a Letter of Intent (“LOI”) with owner Lalgy Transport to further invest in Black Bulls, a Mozambican football team and current Mocambola league champions in the top tier Once fulfilled, Brera will become a co-owner of the club, assisting in enhancing its competitiveness and expanding opportunities for Mozambican football domestically, throughout Africa, and abroad Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) approach, just announced a signed Letter of Intent (“LOI”) with owner…

FridayMar 07, 2025 10:45 am

D-Wave Quantum Inc. (NYSE: QBTS), Staque Develop Hybrid Quantum Application to Optimize Autonomous Agriculture Vehicles

The companies expect the application to accelerate autonomy in agriculture, streamlining agricultural operations. The technology aims to enhance efficiency in large-scale farming by providing real-time optimization solutions. The initiative is part of a broader strategic partnership between D-Wave and Staque to accelerate commercial adoption of annealing quantum computing. D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, and the first supplier of production-grade quantum computers, and Staque, a leading consulting and development practice in AI, blockchain and quantum computing, collaborated to develop a hybrid-quantum system designed to optimize the movements of autonomous agricultural vehicles…

FridayMar 07, 2025 10:00 am

Adageis Secures $2M Seed Funding to Expand AI-Driven Healthcare Solutions

Adageis closed a $2 million seed round at the end of Q4 2024 to support operational expansion, with the funding to enhance backend operations for next-generation software upgrades. Upgraded Electronic Health Record EHR”) connectivity will facilitate integration with over 90 EHR systems, while increased sales force investment will help accelerate growth and market adoption. Adageis' AI-powered platform is designed to streamline healthcare operations, optimize provider revenue, and improve patient care outcomes. Adageis, a forward-thinking healthcare technology company reshaping patient care through flexible AI-centric software solutions for healthcare organizations, has secured $2 million in seed financing to enhance its operations and…

ThursdayMar 06, 2025 10:45 am

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Looks to Benefit from Higher Palladium Price

One industry expert projects that the price of palladium could double within the next decade. The projected increase in palladium prices bodes well for PLG. To further strengthen its strategic position, PLG has been exploring opportunities to enhance its processing capabilities. The palladium market may be poised for a transformation over the next decade, with one industry analyst forecasting a price increase. The anticipated higher price would present a promising opportunity for companies deeply invested in palladium, such as Platinum Group Metals (NYSE American: PLG) (TSX: PTM). As an emerging player in the palladium sector, Platinum Group Metals stands to…

WednesdayMar 05, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Pioneers Systemic Virotherapy with RTNova Platform

Calidi's RTNova platform leverages engineered enveloped vaccinia viruses designed for systemic delivery. Calidi's groundbreaking virotherapy holds “immense promise in revolutionizing the treatment landscape for cancer patients with advanced solid tumors,” says CEO. Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company at the forefront of developing innovative immunotherapies for cancer treatment. Most recently, the company has captured the spotlight for the development of its proprietary systemic platform, RTNova (https://ibn.fm/Z4pM3). The platform represents a significant advancement in systemic virotherapy, particularly in the utilization of enveloped virotherapies to target metastatic tumors across the body. Antitumor virotherapy employs viruses that selectively infect…

Site Search

Company Search

Category: Articles